Clinical trial
Intralesional Therapies For Cutaneous Viral Warts: A Comparative Analysis Of Vitamin D3 And Acyclovir
NCT07448844 is registered in ClinicalTrials.gov with Riphah International University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intralesional Therapies For Cutaneous Viral Warts: A Comparative Analysis Of Vitamin D3 And Acyclovir
- Lead sponsor
- Riphah International University
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- February 20, 2026
- Completion date
- September 20, 2026
- Enrollment
- 40 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
common wart, common warts (verruca vulgaris), flat wart, plantar wart, viral wart, wart, warts hand, warts of foot